JPH0737355B2 - Blood drying method - Google Patents

Blood drying method

Info

Publication number
JPH0737355B2
JPH0737355B2 JP1040782A JP4078289A JPH0737355B2 JP H0737355 B2 JPH0737355 B2 JP H0737355B2 JP 1040782 A JP1040782 A JP 1040782A JP 4078289 A JP4078289 A JP 4078289A JP H0737355 B2 JPH0737355 B2 JP H0737355B2
Authority
JP
Japan
Prior art keywords
blood
treatment
protein
coagulated
globin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1040782A
Other languages
Japanese (ja)
Other versions
JPH02221176A (en
Inventor
俊昌 山本
功 安達
晴彦 永沢
Original Assignee
株式会社新潟鐵工所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社新潟鐵工所 filed Critical 株式会社新潟鐵工所
Priority to JP1040782A priority Critical patent/JPH0737355B2/en
Publication of JPH02221176A publication Critical patent/JPH02221176A/en
Publication of JPH0737355B2 publication Critical patent/JPH0737355B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/20Fertilizers of biological origin, e.g. guano or fertilizers made from animal corpses

Landscapes

  • Fodder In General (AREA)
  • Fertilizers (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] この発明は、畜産動物の食肉解体時に排出される血液を
肥料あるいは飼料として加工するための血液の乾燥処理
法に関する。
Description: TECHNICAL FIELD The present invention relates to a blood drying treatment method for processing blood discharged during meat slaughter of livestock animals as fertilizer or feed.

[従来の技術] 牛や豚等の畜産動物を食肉解体する際に排出される血液
中には、蛋白質が多量に含有されている。この血中蛋白
質を有効利用する方法の一つとして、血液を乾燥し、肥
料あるいは飼料として使用することが行われている。
[Prior Art] A large amount of protein is contained in blood discharged when meat of livestock animals such as cows and pigs is slaughtered. As one of the methods for effectively using this blood protein, blood is dried and used as fertilizer or feed.

この食肉解体時に外出される血液を処理するには、従来
から種々の方法が提案されているが、蛋白質の熱変性凝
固を利用した方法が一般に利用されている。この方法
は、血液中に高温蒸気を噴出させる等の手段により血中
の蛋白質を熱変性させて凝固させた後、固液分離装置に
て凝固血液のみを分取し、この凝固血液を乾燥させる方
法である。
Although various methods have been proposed in the past for treating blood that goes out during meat slaughter, a method that utilizes heat-denatured coagulation of proteins is generally used. In this method, the protein in the blood is heat-denatured and coagulated by means such as ejecting high-temperature steam into the blood, and then only the coagulated blood is separated by a solid-liquid separation device, and the coagulated blood is dried. Is the way.

[発明が解決しようとする課題] ところが上記のような方法では、血中蛋白質の凝固を熱
変性のみによって行うので、蛋白質の凝固効率が低く、
特に可溶性蛋白質の流出を免れず、処理効率が低いとい
う不都合があった。また熱変性によって凝固した蛋白質
は粘稠性を示す塊粒物となるので、熱変性処理後の血液
は塊粒物を含有した粘性の高いスラッジ状流体となり、
固液分離工程および乾燥工程での取り扱い性が低下する
という不都合があった。さらに上記塊粒物を含有したス
ラッジ状流体を乾燥すると、嵩密度の低い微粉状とな
り、顆粒状の製品が得られないという不都合もあった。
[Problems to be Solved by the Invention] However, in the above method, the blood protein is coagulated only by heat denaturation, so that the protein coagulation efficiency is low,
In particular, there is a disadvantage that the efficiency of treatment is low because the soluble protein is not escaped. Further, since the protein coagulated by heat denaturation becomes agglomerates that exhibit viscosity, the blood after heat denaturation becomes a highly viscous sludge-like fluid containing agglomerates,
There is a disadvantage that the handling property in the solid-liquid separation step and the drying step is lowered. Further, when the sludge-like fluid containing the above-mentioned agglomerates is dried, it becomes a fine powder having a low bulk density, and there is a disadvantage that a granular product cannot be obtained.

この発明は上記課題を解決するためになされたものであ
って、血中蛋白質を高効率で凝固させ、かつ取り扱い性
の良好な顆粒状の蛋白質凝固物からなる製品を容易に得
られるような乾燥処理法を提供することを目的としてい
る。
The present invention has been made to solve the above-mentioned problems, and is a method of coagulating blood proteins with high efficiency, and drying to easily obtain a product made of a granular protein coagulated product with good handleability. It is intended to provide a treatment method.

[課題を解決するための手段] この発明の血液の乾燥処理法は、血液に、酸を添加した
後にアルカリによって中和するpH処理を施したのちに、
熱変性処理を施し、ついで乾燥することを解決手段とし
た。ここでいう血液とは、全血および全血を血漿と血球
液に分離した後の血球液を含む。
[Means for Solving the Problems] The method for drying blood according to the present invention is characterized in that after the blood is subjected to pH treatment for neutralizing with an alkali after adding an acid,
The solution was to subject it to a heat denaturation treatment and then to dry it. The blood referred to herein includes whole blood and blood cell fluid obtained by separating whole blood into plasma and blood cell fluid.

[作用] 血中蛋白質を熱変性凝固させる前に、pH処理を施すの
で、蛋白質を高効率で凝固させることができる。
[Action] Since the pH treatment is performed before the blood protein is heat-denatured and coagulated, the protein can be coagulated with high efficiency.

以下、この発明を詳しく説明する。Hereinafter, the present invention will be described in detail.

この発明で用いられる血液は、豚、牛、羊などに代表さ
れる畜産動物の食肉解体時に排出されるものなどを用い
ることができ、鮮血であっても時間が経過した古血であ
ってもよいが、古血であると流動性が低下する等の取り
扱い上の点および後述するpH処理時の試薬量が増加する
点などを考慮すると解体時直後の鮮血であることが好ま
しい。
The blood used in the present invention may be one that is discharged during meat slaughter of livestock animals represented by pigs, cows, sheep, etc., and it may be fresh blood or old blood over time. Although good, old blood is preferably fresh blood immediately after disassembling in consideration of handling points such as decrease in fluidity and increase in reagent amount during pH treatment described later.

第1図はこの発明の血液の乾燥処理法の一例の各工程を
示したものである。以下、この工程図に沿って説明す
る。
FIG. 1 shows each step of an example of the method for drying blood according to the present invention. The process will be described below with reference to the process chart.

溶血処理 この発明方法の実施に際しては、まず食肉解体時等に排
出された畜産動物等の血液を採取した後、撹拌等の溶血
処理を施す。この溶血処理は、既に血液中で凝固した蛋
白質の一部を均一に液化すると共に、後のpH処理におい
て赤血球中のグロビン蛋白質の凝固をより高効率で行え
るようにするためのものであって、赤血球膜を破壊して
その内部に含有されているヘモグロビンを血液中に分散
させるためのものである。なお、この発明方法の実施に
際しては、この溶血処理を必ずしも行なう必要はなく、
採血後、後述するpH処理を直接行ってもよい。
Hemolysis Treatment In carrying out the method of the present invention, first, blood of a livestock animal or the like discharged during meat slaughter is collected, and then hemolysis treatment such as stirring is performed. This hemolytic treatment is for uniformly liquefying a part of the protein already coagulated in blood, and for enabling the coagulation of globin protein in erythrocytes in the subsequent pH treatment with higher efficiency, The purpose is to destroy the red blood cell membrane and disperse the hemoglobin contained therein into the blood. In carrying out the method of the present invention, it is not always necessary to perform this hemolytic treatment,
After blood collection, the pH treatment described below may be performed directly.

pH処理 −a酸添加 畜産動物等から採取された血液あるいは上記溶血処理が
施された血液のpHが1.7以上4.0以下となるように、塩酸
等の酸を撹拌しつつ適宜添加する。この酸添加工程は、
血液中の蛋白質の大部分を占めるヘモグロビンの色素成
分であるヘムと蛋白質成分であるグロビンとの結合を切
断して、中性水中への溶解度の低いグロビンとするため
のものであって、酸の添加量は処理する血液の種類およ
び性状によって適宜選択される。血液中に含有される赤
血球数およびヘモグロビン数は動物の種によって異な
り、固体差があるうえ、鮮血と古血とでもその数が変化
するので、酸を添加し撹拌しつつpHを測定し、そのpHが
1.7以上4.0以下、特に好ましくは3以上4以下となるよ
うにする。これは血液のpHが3以上4以下であると、ヘ
ムをグロビンとの結合の切断が最も効率良く行なわれる
ためである。
pH treatment-a Acid addition Acid such as hydrochloric acid is appropriately added with stirring so that the pH of blood collected from livestock animals or the blood subjected to the above hemolysis treatment will be 1.7 or more and 4.0 or less. This acid addition step is
It is for cleaving the bond between heme, which is the pigment component of hemoglobin, which occupies most of the proteins in blood, and globin, which is a protein component, to give globin with low solubility in neutral water. The amount to be added is appropriately selected depending on the type and properties of blood to be treated. The number of red blood cells and the number of hemoglobin contained in blood differ depending on the species of the animal, and there are individual differences, and since the numbers also change in fresh blood and old blood, pH is measured while adding acid and stirring, pH is
1.7 or more and 4.0 or less, and particularly preferably 3 or more and 4 or less. This is because when the pH of blood is 3 or more and 4 or less, the binding of heme with globin is most efficiently cleaved.

−b中和処理 対で、上記酸添加によって、pHが1.7以上4.0以下とされ
た血液に、水酸化ナトリウム等のアルカリを撹拌しつつ
添加して中和する。この中和処理によって、グロビンは
不溶の凝固物として血液中に析出する。これはヘモグロ
ビンのヘムとグロビンへの分解反応が不可逆的であるこ
とと、グロビンの水への溶解性とを利用したものであ
る。すなわちヘムとグロビンとの結合が一端切断された
後は、液性によって結合が再生しないことと、グロビン
はpH6以下の酸性水中には高い溶解度で溶解するが、pH7
ないし8程度の中性から弱アルカリ性水中には不溶性で
あることを利用し、酸添加された血液を中和することに
よってグロビンを不溶性の凝固物として析出させること
ができる。そしてこの中和処理の際に血液を撹拌するこ
とにより、後述する熱処理工程で熱凝固して析出する蛋
白質の核となるような微細なグロビン凝固物を析出させ
ることができる。このグロビン凝固物を析出させて核と
することにより、熱凝固した蛋白質は、従来のようにブ
ロック状の大きな塊粒状物に成長するのを防止すること
ができる。
-B Neutralization treatment In the pair, neutralization is carried out by adding an alkali such as sodium hydroxide with stirring to blood whose pH has been adjusted to 1.7 or more and 4.0 or less by the above acid addition. By this neutralization treatment, globin is deposited in blood as an insoluble coagulation product. This utilizes the irreversible decomposition reaction of hemoglobin into heme and globin, and the solubility of globin in water. That is, after the bond between heme and globin is once cleaved, the bond does not regenerate due to liquidity, and globin dissolves in acidic water with a pH of 6 or less with high solubility, but pH 7
Utilizing the fact that it is insoluble in neutral to weakly alkaline water of about 8 to 8, globin can be precipitated as an insoluble coagulated product by neutralizing the acid-added blood. By stirring the blood during this neutralization treatment, it is possible to deposit a fine globin coagulum that becomes a nucleus of a protein that is thermally coagulated and precipitated in the heat treatment step described later. By precipitating this globin coagulated substance to form a nucleus, the thermally coagulated protein can be prevented from growing into a block-like large lump and granular material as in the conventional case.

また、このpH処理の際に凝固物として析出する蛋白質
は、赤血球中に含有されるヘモグロビンを分解して得ら
れるグロビンのみであって、血液中のその他の蛋白質成
分であるアルブミンやグロブリン等は溶解成分として液
中に残存しているので、pH処理後の血液は砂利状あるい
は水分の多い泥状のスラッジ状となるものの、粘性は低
く、流動性に富むものとなるので、取り扱い性は低下し
ない。
Further, the protein precipitated as a coagulation product during this pH treatment is only globin obtained by decomposing hemoglobin contained in erythrocytes, and other protein components such as albumin and globulin in blood are dissolved. Since it remains in the liquid as a component, the blood after pH treatment becomes gravel or mud-like sludge with a large amount of water, but it has low viscosity and is highly fluid, so handleability does not deteriorate. .

このpH処理に必要とする酸およびアルカリの添加量は、
処理する血液の種類や状態によって適宜選択する。たと
えば牛の血液の方が豚の血液よりも凝固しやすく、凝固
物は砂利状となる。また鮮血よりも古血の方が多量の酸
を必要とするので、この発明の方法で血液を乾燥するに
は出来るだけ早いうちにpH処理を施した方が良い。
The addition amount of acid and alkali required for this pH treatment is
It is appropriately selected depending on the type and condition of blood to be treated. For example, bovine blood is easier to coagulate than pig blood, and the coagulated material is gravel. Further, since old blood requires a larger amount of acid than fresh blood, it is better to perform pH treatment as soon as possible in order to dry blood by the method of the present invention.

熱変性処理 上記、pH処理によってグロビンを凝固させて微細な核
が形成された血液を撹拌しつつ加熱して、pH処理によっ
て凝固しない血中の蛋白質成分を熱変性させることによ
り凝固させる。pH処理によって凝固しない血中の蛋白質
成分とは、血漿中に含有されるアルブミンやグロブリン
および上記pH処理によって凝固せずに溶解成分として
溶在しているごく少量のグロビンなどである。加熱温度
は液温が60℃以上75℃以下となるようにし、加熱方式は
血液が満たされている容器外からの外部加熱方法であっ
ても、容器内に発熱体を設ける内部加熱方式であっても
よい。加熱温度が、60℃以下であると、この熱変性処理
工程の効率が低くなるので好ましくなく、また75℃以上
であると、一部の蛋白質の炭化等が進行すると共に、蛋
白質の熱凝固が急激に進行し、大きな塊粒物が多量に発
生し、製品の品質低下が起きるので好ましくない。
Heat Denaturation Treatment Above, the blood in which globin is coagulated by the pH treatment to form fine nuclei is heated while stirring, and the protein component in the blood which is not coagulated by the pH treatment is thermally denatured to be coagulated. The protein components in blood that are not coagulated by the pH treatment include albumin and globulin contained in plasma and a very small amount of globin that is dissolved as a dissolved component without being coagulated by the pH treatment. The heating temperature is such that the liquid temperature is 60 ° C or higher and 75 ° C or lower, and the heating method is an internal heating method in which a heating element is provided in the container even if it is an external heating method from outside the container filled with blood. May be. When the heating temperature is 60 ° C. or lower, the efficiency of this heat denaturation treatment step is low, which is not preferable, and when the heating temperature is 75 ° C. or higher, carbonization of a part of the protein proceeds and the heat coagulation of the protein is It is not preferable because it rapidly progresses, a large amount of large aggregates are generated, and the quality of the product deteriorates.

熱変性処理が施される血液中には、蛋白質の熱変性によ
って凝固が起こる際の核となるグロビン凝固物が既に上
記pH処理によって形成されているので、この熱変性処
理によって凝固する蛋白質は、容器壁面よりもグロビン
凝固物からなる核の表面に優先的に析出するので、処理
効率が低下しない。さらにはグロビン凝固物を核として
いるので、ブロック状の大きな塊粒物が形成されること
がなく、後の乾燥処理を容易に行うことができる。
In blood that is subjected to heat denaturation treatment, since the globin coagulum that serves as the nucleus when coagulation occurs due to heat denaturation of the protein has already been formed by the above pH treatment, the protein that is coagulated by this heat denaturation treatment is: The treatment efficiency does not decrease because it is preferentially deposited on the surface of the nuclei made of globin coagulate rather than on the wall surface of the container. Furthermore, since the globin coagulated product is the core, large block-shaped aggregates are not formed, and the subsequent drying process can be easily performed.

このようにして蛋白質凝固物が形成された血液を下記乾
燥処理を施す乾燥器内へ供給する。この際に、遊離水を
脱水する脱水工程を施し、濃縮してもよいが、顆粒状の
乾燥血液を得るためには、若干量の遊離水を含有したま
ま乾燥処理を施すことが好ましい。
The blood on which the protein coagulated product is formed in this manner is supplied into a dryer which is subjected to the following drying treatment. At this time, a dehydration step of dehydrating the free water may be performed to concentrate, but in order to obtain granular dry blood, it is preferable to perform the drying treatment while containing a slight amount of the free water.

乾燥処理 次に、熱凝固した蛋白質を含有した血液を、十分に撹拌
しつつ、血液の沸点付近の加熱温度(および100℃程
度)で加熱し、乾燥させる。
Drying Treatment Next, the blood containing the heat-coagulated protein is heated at a heating temperature near the boiling point of blood (and about 100 ° C.) while being sufficiently stirred, and dried.

この乾燥処理工程は、上記熱変性処理によっても凝固
し得なかった一部の水溶性蛋白質を高温加熱により凝固
させると共に、血液中の水分を蒸発させて乾燥血液とす
る工程であって、この工程を上記熱変性処理の後に施
すことにより、高効率で血液中の蛋白質を凝固物として
得ることができる。またこの処理工程では、血液中の水
溶性蛋白質の熱凝固の方が、水分の蒸発よりも優先的に
進行すると共に、蛋白質の熱凝固後の水分の蒸発により
蛋白質凝固物からなる粒子が大きな塊粒物に凝集するこ
とがないので、得られる乾燥血液は顆粒状となる。
This drying treatment step is a step of coagulating a part of the water-soluble proteins that could not be coagulated by the heat denaturation treatment by heating at high temperature, and evaporating water in the blood to give dried blood. By carrying out after the above heat denaturation treatment, the protein in blood can be obtained as a coagulum with high efficiency. In addition, in this treatment step, heat coagulation of water-soluble protein in blood progresses preferentially over evaporation of water, and at the same time, particles of protein coagulation are formed into large lumps due to evaporation of water after heat coagulation of protein. The dried blood obtained is in the form of granules because it does not aggregate into granules.

またこの処理の際に血液は、沸騰状態になるため、激し
い水分蒸発が起き、この時に発生する多量の水蒸気と加
熱容器内の撹拌作用によって凝固蛋白質の分散が行なわ
れるので、グロビン凝固物が大きな塊粒物となるのを防
止し、顆粒状の乾燥血液を得ることができる。
Further, during this treatment, the blood is in a boiling state, so that vigorous water evaporation occurs, and a large amount of steam generated at this time and the stirring action in the heating container disperse the coagulation protein, so that the globin coagulation product is large. It is possible to prevent agglomerates and obtain granular dry blood.

上記のように、この発明の血液の乾燥処理法は、血液中
の蛋白質の各成分の物理的、化学的性質をそれぞれ利用
し、pH処理、熱変性処理、乾燥処理との3回に分けて行
うものであるので、従来の処理法に比較して格段に処理
効果が向上すると共に、顆粒状の高品質の乾燥血液を得
ることができる。
As described above, the method for drying blood according to the present invention utilizes the physical and chemical properties of each component of protein in blood, and is divided into three steps of pH treatment, heat denaturation treatment and drying treatment. Since it is performed, the treatment effect is remarkably improved as compared with the conventional treatment method, and granular high-quality dried blood can be obtained.

[実施例] (実施例) 食肉解体場から固形分を20重量%含有した豚の新鮮な全
血を10l入手し、これを乳化機にて500rpmで5分間撹拌
し、既に凝集した固形物を均一に液化すると共に溶血し
て赤血球内に含有されるヘモグロビンを分散させた血液
試料とした。
[Example] (Example) 10 liters of fresh whole blood of a pig containing 20% by weight of solid content was obtained from a meat slaughterhouse, and stirred for 10 minutes at 500 rpm in an emulsifying machine to remove already solidified solid matter. A blood sample in which hemoglobin contained in erythrocytes was dispersed by uniform liquefaction and hemolysis was prepared.

次にこの溶血した血液試料をゆっくりと撹拌しつつ、35
重量%の塩酸を、血液試料のpHが3.5となるまで滴下し
たところ100mlを要し、血液資料は黒褐色の泥状物とな
った。ついでこの黒褐色の泥状血液をゆっくりと撹拌し
つつ、10規定の水酸化ナトリウムを、血液試料のpHが7.
0となるまで滴下したところ100mlを要し、血液資料は細
かい砂利状の凝固物が分散された泥状物となった。
The hemolyzed blood sample is then gently stirred for 35
When 100% by weight of hydrochloric acid was added dropwise until the pH of the blood sample reached 3.5, the blood sample became a blackish brown mud. Then, while slowly stirring this dark brown mud-shaped blood, 10N sodium hydroxide was added to the blood sample at a pH of 7.
When it was dropped until it reached 0, 100 ml was required, and the blood sample was a mud-like material in which fine gravel-like coagulated material was dispersed.

この砂利状の凝固物が分散された泥状の血液試料を20lS
US容器内へ取り、容器の底部を1.2kWの電熱器で加熱し
つつ撹拌した。30分加熱後に液温は63℃となり、砂利状
の熱凝固物が析出した泥状物となった。
20 lS of the blood sample in the form of mud in which this gravel-like coagulated substance is dispersed
It was taken into a US container, and the bottom of the container was stirred while heating with a 1.2 kW electric heater. After heating for 30 minutes, the liquid temperature became 63 ° C., and it became a mud-like substance in which a gravel-like thermally solidified substance was deposited.

上記工程が施された血液試料40lを容易し、これを1軸
の蒸気加熱の伝導伝熱型撹拌型乾燥器(ホソカワミクロ
ン(株)製)のトーラスディスクTDS−12−3)に投入
し、乾燥した。この時の運転条件は以下の通りである。
40 l of the blood sample that has been subjected to the above steps is easily prepared, and this is put into a torus disk TDS-12-3 of a uniaxial steam-heated conduction heat transfer type stirring dryer (manufactured by Hosokawa Micron Co., Ltd.) and dried. did. The operating conditions at this time are as follows.

加熱方法:130℃(1.7kg/cm2g)の水蒸気をジャケット
およびロータ内に導入した。
Heating method: 130 ° C. (1.7 kg / cm 2 g) steam was introduced into the jacket and rotor.

ロータの回転数:40RPM 血液の供給方法:40lを全量投入したバッチ乾燥運転を行
った。
Rotor speed: 40 RPM Blood supply method: A batch drying operation was performed in which the total amount of 40 l was added.

この乾燥処理を90分行って、黒褐色の粉末状の乾燥血液
が得られた。この乾燥血液の物性を調べたところ以下の
ような結果の密度の高い顆粒状物であることが確認でき
た。
This drying treatment was performed for 90 minutes to obtain black brown powdery dry blood. When the physical properties of this dried blood were examined, it was confirmed that the dried blood was a granular material having a high density.

密度:0.81g/cm3 水分含有量:9.2% 粒度分布: 1.0mm以上 31重量% 1.0〜0.5mm 19重量% 0.5〜0.25mm 40重量% 0.25〜0.1mm 8重量% 0.1mm以下 2重量% (比較例) 実施例で用いたと、全く同様の全血を200gづつ別個にビ
ーカーに採取し、一方の血液試料には実施例と全く同様
にしてpH処理を施し、他方にはpH処理を施さないまま、
共にホットプレート上に載置して全く同一条件にて撹
拌、加熱して、pH処理の有効性を調べた。
Density: 0.81g / cm 3 Moisture content: 9.2% Particle size distribution: 1.0mm or more 31% by weight 1.0 to 0.5mm 19% by weight 0.5 to 0.25mm 40% by weight 0.25 to 0.1mm 8% by weight 0.1mm or less 2% by weight ( Comparative Example) When used in Examples, exactly the same whole blood was collected in beakers separately in 200 g portions, one blood sample was subjected to pH treatment in exactly the same manner as in Examples, and the other was not subjected to pH treatment. As it is,
Both were placed on a hot plate, stirred and heated under exactly the same conditions, and the effectiveness of pH treatment was investigated.

pH処理を施した血液試料は、液温が65℃になると共に、
熱凝固を開始し、75℃では遊離水がなくなり、砂利状物
となった。またビーカー壁への付着はなく、得られた砂
利状物も粒径の揃ったものであった。
A blood sample that has been subjected to pH treatment has a liquid temperature of 65 ° C,
Thermal coagulation started, and free water disappeared at 75 ° C, resulting in gravel. Further, there was no adhesion to the beaker wall, and the obtained gravel-like material had a uniform particle size.

これに対して、pH未処理の血液試料は、加熱によっても
凝固が進行しにくく、75℃に至って始めて凝固を開始
し、以後加熱を続けると団子状の凝固物が発生し、ビー
カー壁へも多量の凝固物が付着した。
On the other hand, a blood sample that is not treated with pH is less likely to coagulate even when heated, and starts coagulating only when the temperature reaches 75 ° C, and if heating is continued thereafter, a coagulum in the form of dumplings is generated and even on the beaker wall. A large amount of coagulated material adhered.

以上の結果からpH処理を血液に施すことにより、熱変性
処理時に必要とする熱量を低減させ、容器壁への付着を
防止すると共に、顆粒状の凝固物を容易に得られるよう
になることが確認でき、pH処理は非常に有効な処理工程
であることが確認できた。
From the above results, by applying pH treatment to blood, it is possible to reduce the amount of heat required during heat denaturation treatment, prevent adhesion to the container wall, and easily obtain a granular coagulated product. It was confirmed that pH treatment was a very effective treatment process.

[発明の効果] 以上説明したように、この発明の血液の乾燥処理法は、
血液に、酸を添加した後にアルカリによって中和するpH
処理を施したのちに、熱変性処理を施し、ついで乾燥す
るものであるので、高い処理効率で、嵩密度が高く取り
扱いの良好な乾燥血液を得ることができる。
[Effects of the Invention] As described above, the method for drying blood according to the present invention is
PH neutralized by alkali after adding acid to blood
Since the treatment is followed by heat denaturation and then drying, it is possible to obtain dry blood with high treatment efficiency, high bulk density and good handling.

またこの処理法は、血液中の蛋白質の各成分の物理的、
化学的性質を利用し、pH処理、熱変性処理、乾燥処理と
の3回に別けてこの順に凝固処理を行うものであるの
で、従来の処理法に比較して格段に蛋白質の凝固効率が
向上すると共に、顆粒状の高品質の乾燥血液を得ること
ができる。
In addition, this processing method is based on physical treatment of each component of protein in blood,
Utilizing chemical properties, the coagulation treatment is performed in this order in three steps, pH treatment, heat denaturation treatment, and drying treatment, so protein coagulation efficiency is significantly improved compared to conventional treatment methods. At the same time, granular high-quality dried blood can be obtained.

また特にpH処理を施すことにより、熱変性処理および加
熱処理等に必要とする熱量を低減させることが可能とな
り、低コストにて高品質の乾燥血液を得ることができる
効果がある。
Further, in particular, by performing the pH treatment, it is possible to reduce the amount of heat required for the heat denaturation treatment, the heat treatment, etc., and it is possible to obtain high-quality dried blood at low cost.

【図面の簡単な説明】[Brief description of drawings]

第1図は、この発明の乾燥処理法の一実施例の各工程を
示した工程図である。 ……pH処理、……熱変性処理、……乾燥処理。
FIG. 1 is a process drawing showing each process of one embodiment of the drying treatment method of the present invention. ...... pH treatment, ...... heat denaturation treatment, ...... drying treatment.

フロントページの続き (72)発明者 永沢 晴彦 東京都大田区蒲田本町1丁目9番3 株式 会社新潟鉄工所エンジニアリングセンター 内 (56)参考文献 特公 昭28−4016(JP,B1) 特公 昭29−7163(JP,B1) 特公 昭30−1318(JP,B1) 特公 昭52−5779(JP,B2)Front page continuation (72) Inventor Haruhiko Nagasawa 1-9-3 Kamatahonmachi, Ota-ku, Tokyo Inside Niigata Iron Works Engineering Center Co., Ltd. (56) References JP-B 28-4016 (JP, B1) JP-B Sho 29 -7163 (JP, B1) JP 30-3018 (JP, B1) JP 52-5779 (JP, B2)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】血液に、酸を添加した後にアルカリによっ
て中和するpH処理を施した後に、熱変性処理を施し、つ
いで乾燥することを特徴とする血液の乾燥処理法。
1. A method of drying blood, which comprises subjecting blood to pH treatment for neutralizing with an alkali after adding an acid, heat denaturing treatment, and then drying.
JP1040782A 1989-02-21 1989-02-21 Blood drying method Expired - Lifetime JPH0737355B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1040782A JPH0737355B2 (en) 1989-02-21 1989-02-21 Blood drying method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1040782A JPH0737355B2 (en) 1989-02-21 1989-02-21 Blood drying method

Publications (2)

Publication Number Publication Date
JPH02221176A JPH02221176A (en) 1990-09-04
JPH0737355B2 true JPH0737355B2 (en) 1995-04-26

Family

ID=12590197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1040782A Expired - Lifetime JPH0737355B2 (en) 1989-02-21 1989-02-21 Blood drying method

Country Status (1)

Country Link
JP (1) JPH0737355B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021552A (en) * 1975-06-27 1977-05-03 A. H. Robins Company, Incorporated 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES

Also Published As

Publication number Publication date
JPH02221176A (en) 1990-09-04

Similar Documents

Publication Publication Date Title
CA2157778C (en) Method for producing gelatin
US5276138A (en) Process for solubilizing animal hair
US3131130A (en) Method of producing soluble collagen
EP0033519B1 (en) Process and apparatus for the production of powdered protein materials from animal raw material, especially offal
US4347259A (en) Method for reducing the bacterial population of blood powder
US3936375A (en) Process for dewatering a proteinaceous, aqueous sludge and for removing and recovering precipitating agents from a precipitate containing proteinaceous substances
JPH0737355B2 (en) Blood drying method
US4666725A (en) Process for producing blood powder
BE1016630A3 (en) Processing blood from slaughterhouse waste to form product useful in e.g. food or animal feed, comprises coagulation, hydrolysis with base and addition of acid to form precipitate
CN109170118A (en) A kind of preparation method of Silkworm pupa protein
CA1152894A (en) Process for the production of new type of heparin-containing raw material
CA1197236A (en) Meat protein product and process
US609057A (en) denmark
US3778425A (en) Process for the manufacture of granular or powdery purified whole egg protein
US4518771A (en) Process for the production of heparin-containing particulate products
US1632321A (en) Blood-treating process
JP2000515569A (en) Removal of proteins from aqueous media by sedimentation
JPS6163247A (en) Production of globin protein
EP0048771B1 (en) Low temperature rendering process and a plant for rendering animal or vegetable raw material
US2494148A (en) Method of purifying lactalbumin
JPS5978644A (en) Preparation of salt consisting essentially of calcium from milky raw material
JPS6214250B2 (en)
RU2010540C1 (en) Method for production of pectin
Soest Use of detergents in the analysis of fibrous feeds. I. Preparation of fiber residues of low nitrogen content
US3684790A (en) Method of separating proteins from proteinaceous animal material using mucilage of flax, quince or fleawort